ESR1 and breast carcinoma: We found that MSL TNBC cell lines displayed lower global m6A levels than luminally differentiated ER+ breast cancer cell lines (MCF7 and T47D) and ER+HER2+ breast cancer cell lines (ZR-75–1 and BT474) (Fig. 1a).